Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Inactivated rabies viruses carrying canine distemper glycoproteins protect against both pathogens

02.02.2017

Currently licensed live attenuated canine distemper vaccines are highly effective. However, they retain the potential to cause disease in very susceptible species. Researchers at Paul-Ehrlich-Institut and Thomas Jefferson University have generated an inactivated candidate vaccine that induces protective immunity against both rabies and canine distemper and has an excellent safety profile. The candidate vaccine consists of a mix of two recombinant inactivated rabies viruses that carry either one of the two canine distemper glycoproteins in addition to its own glycoprotein.The results are published in the online edition of Journal of Virology 1 February 2016.

Rabies and canine distemper are among the most dangerous and lethal viral diseases afflicting carnivores. Rabies can also be transmitted to humans via bite from rabies-infected animals. It attacks the nervous system and can be deadly if not treated immediately.


Cells infected with canine distemper virus fuse to neighboring uninfected cells to form syncytia. Antibodies against canine distemper virus are used to stain the infected cells with a red dye

Source: PEI


Cells infected with rabies virus were stained with antibodies from rabies-immunized animals. These cells can be seen by stimulating a fluorescent dye attached to the antibodies, which glows green.

Source: PEI

Rabies vaccines contain inactivated virus particles and have an excellent stability and safety profile. For vaccination against canine distemper virus, which causes a measles-like disease in its hosts, live-attenuated viruses are used. These vaccine viruses replicate in the vaccinated animals to a certain extent and can lead to severe disease in highly susceptible species.

Prof. Dr. Veronika von Messling's group at the Veterinary Medicine Division, Paul-Ehrlich-Institut, in collaboration with Dr. Matthias Schnell's group at Thomas Jefferson University genetically engineered the rabies virus vaccine strain to carry one of the canine distemper virus glycoproteins in addition to its own glycoprotein. The protective immune response is directed against these proteins. Candidate vaccines were then produced following the purification and inactivation protocols used for rabies vaccines.

The researchers first demonstrated that a single shot was sufficient to elicit protective rabies antibody titers in ferrets. However, protection against canine distemper was only achieved when animals were immunized with a mix of viruses carrying both canine distemper virus glycoproteins. The researchers conclude that immune responses against both glycoproteins are necessary to protect from canine distemper.

"Our rabies-based vector is a promising platform for the development of new morbillivirus vaccines" explains von Messling. "It eliminates the risk for vaccine-induced disease and at the same time greatly increases the temperature stability compared to live-attenuated morbillivirus vaccines."

Original Publication

Da Fontoura Budaszewski R, Hudacek A, Sawatsky B, Krämer B, Xiangping Y, Schnell MJ, von Messling V (2017): Inactivated Recombinant Rabies Viruses Displaying Canine Distemper Virus Glycoproteins Induce Protective Immunity Against Both Pathogens.
J Virol Feb 01 [Epub ahead of print].
doi: 10.1128/JVI.02077-16


The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, in Langen near Frankfurt/Main is a senior federal authority reporting to the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG). It is responsible for the research, assessment, and marketing authorisation of biomedicines for human use and immunological veterinary medicinal products. Its remit also includes the authorisation of clinical trials and pharmacovigilance, i.e. recording and evaluation of potential adverse effects.

Other duties of the institute include official batch control, scientific advice and inspections. In-house experimental research in the field of biomedicines and life science form an indispensable basis for the manifold tasks performed at the institute.

The Paul-Ehrlich-Institut, with its roughly 800 members of staff, also has advisory functions nationally (federal government, federal states (Länder)), and internationally (World Health Organisation, European Medicines Agency, European Commission, Council of Europe etc.).

Weitere Informationen:

http://jvi.asm.org/content/early/2017/01/26/JVI.02077-16.abstract - Abstract of the publicaton
http://www.pei.de/EN/information/journalists-press/press-releases/2017/03-inacti... - this press release on the Paul-Ehrlich-Institut Website

Dr. Susanne Stöcker | idw - Informationsdienst Wissenschaft

More articles from Health and Medicine:

nachricht Finnish research group discovers a new immune system regulator
23.02.2018 | University of Turku

nachricht Minimising risks of transplants
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Attoseconds break into atomic interior

A newly developed laser technology has enabled physicists in the Laboratory for Attosecond Physics (jointly run by LMU Munich and the Max Planck Institute of Quantum Optics) to generate attosecond bursts of high-energy photons of unprecedented intensity. This has made it possible to observe the interaction of multiple photons in a single such pulse with electrons in the inner orbital shell of an atom.

In order to observe the ultrafast electron motion in the inner shells of atoms with short light pulses, the pulses must not only be ultrashort, but very...

Im Focus: Good vibrations feel the force

A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.

By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Basque researchers turn light upside down

23.02.2018 | Physics and Astronomy

Finnish research group discovers a new immune system regulator

23.02.2018 | Health and Medicine

Attoseconds break into atomic interior

23.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>